ArticleAddiction (Abingdon, England)2026
Weighted prevalence of biochemically verified substance use in healthy adolescents across the USA.
Article in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
15 authors.
Funding
Abstract
BACKGROUND AND
aimsAdolescent substance use is a significant public health concern, though the scope of the problem is difficult to ascertain given reliance on self-reported substance use information. Recent, large cohort studies in adolescents and young adults suggest underreporting of substance use. Analyses here aimed to determine concordance between self-reported substance use and biochemical verification through hair samples and to estimate prevalence of the three most reported substances used by adolescents.
designObservational cohort longitudinal study design. Liquid chromatography and gas chromatography tandem mass spectrometry (LC or GC/MS-MS) were used to test hair samples for biochemically verified substance use, with results compared with self-reported substance use. Multi-step weighting methods estimated prevalence trends of cannabis, alcohol and nicotine use over time, adjusting for discrepancies in sample representation due to recruitment demography, missed visits and hair sample testing. SETTING AND
participantsData came from the United States nationwide Adolescent Brain Cognitive Development Study (n = 11 868; age 9-10 at baseline, age 15-16 at wave 6). Participants were followed annually, with data here from 2016 to 2024. MEASUREMENTS: Hair samples objectively detected at least several days of substance use in a subsample of participants (n
findingsConcordance between self-report and toxicological data improved with age (for cannabis, ages 11-12 = <1%; ages 15-16 = 45%). Weighted estimates of biochemically verified substance use indicated 7.1% [95% confidence interval (CI) = 6.0-8.3] of 15-16 year olds engaged in biochemically detected cannabis use, 0.2% (95% CI = 0.1-0.4) used alcohol and 4.7% (95% CI = 3.7-6.0) used nicotine.
conclusionsIn United States youth, the concordance between self-reported substance use patterns and biochemical verification improves with age. Biochemical verification reflects substantive cannabis and nicotine use by United States youth aged 15-16, supporting combining toxicological and self-report data to improve identification of substance use in youth when possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.